company background image
TPTX logo

Turning Point Therapeutics NasdaqGS:TPTX Stok Raporu

Son Fiyat

US$76.01

Piyasa Değeri

US$3.8b

7D

1.3%

1Y

18.9%

Güncellenmiş

17 Aug, 2022

Veri

Şirket Finansalları +

Turning Point Therapeutics, Inc.

NasdaqGS:TPTX Stok Raporu

Piyasa değeri: US$3.8b

TPTX Stoklara Genel Bakış

Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer.

Turning Point Therapeutics, Inc. Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Turning Point Therapeutics
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$76.01
52 Haftanın En Yüksek SeviyesiUS$82.20
52 Haftanın En Düşük SeviyesiUS$23.77
Beta-0.19
11 Aylık Değişim1.58%
3 Aylık Değişim114.96%
1 Yıllık Değişim18.90%
33 Yıllık Değişim45.39%
5 Yıllık Değişimn/a
Halka arzdan bu yana değişim163.01%

Son Haberler & Güncellemeler

Recent updates

Bristol Myers U.S., German antitrust filings for Turning Point expected very soon - report

Jul 21

We Think Turning Point Therapeutics (NASDAQ:TPTX) Can Afford To Drive Business Growth

Mar 23
We Think Turning Point Therapeutics (NASDAQ:TPTX) Can Afford To Drive Business Growth

Companies Like Turning Point Therapeutics (NASDAQ:TPTX) Are In A Position To Invest In Growth

Dec 06
Companies Like Turning Point Therapeutics (NASDAQ:TPTX) Are In A Position To Invest In Growth

The Take On Turning Point Therapeutics

Dec 03

Industry Analysts Just Made A Sizeable Upgrade To Their Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Revenue Forecasts

Aug 15
Industry Analysts Just Made A Sizeable Upgrade To Their Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Revenue Forecasts

Turning Point Therapeutics (NASDAQ:TPTX) Is In A Strong Position To Grow Its Business

Aug 04
Turning Point Therapeutics (NASDAQ:TPTX) Is In A Strong Position To Grow Its Business

Turning Point Therapeutics gets FDA orphan drug status for TPX-0022 in gastric cancer

Jun 17

Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 08
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Have Insiders Been Selling Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Shares This Year?

Feb 26
Have Insiders Been Selling Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Shares This Year?

Turning Point Therapeutics' repotrectinib shows promising results in lung cancer study

Jan 29

Analysts' Revenue Estimates For Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Are Surging Higher

Jan 22
Analysts' Revenue Estimates For Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Are Surging Higher

We're Not Worried About Turning Point Therapeutics' (NASDAQ:TPTX) Cash Burn

Jan 13
We're Not Worried About Turning Point Therapeutics' (NASDAQ:TPTX) Cash Burn

Turning Point Therapeutics: An Emerging Growth Story In TKI-Resistant Cancers

Dec 28

Is Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Trading At A 48% Discount?

Dec 15
Is Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Trading At A 48% Discount?

Turning Point Therapeutics' lead candidate nabs accelerated review for lung cancer

Dec 08

Turning Point Therapeutics EPS beats by $0.12, beats on revenue

Nov 12

Hissedar Getirileri

TPTXUS BiotechsUS Pazar
7D1.3%-1.4%-1.9%
1Y18.9%20.2%30.4%

Getiri vs. Endüstri: TPTX geçen yıl % 20.2 oranında getiri sağlayan US Biotechs sektörünü aştı.

Getiri vs Piyasa: TPTX geçen yıl % 30.4 oranında getiri sağlayan US Piyasasını aştı.

Fiyat Oynaklığı

Is TPTX's price volatile compared to industry and market?
TPTX volatility
TPTX Average Weekly Movement34.2%
Biotechs Industry Average Movement9.6%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

İstikrarlı Hisse Senedi Fiyatı: TPTX hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: TPTX 'nin haftalık oynaklığı geçtiğimiz yıl boyunca 20% dan 34% a yükseldi.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
2013267Athena Countouriotiswww.tptherapeutics.com

Turning Point Therapeutics, Inc. Temel Bilgiler Özeti

Turning Point Therapeutics'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
TPTX temel i̇stati̇sti̇kler
Piyasa değeriUS$3.81b
Kazançlar(TTM)-US$342.31m
Gelir(TTM)US$1.01m

3,776x

P/S Oranı

-11.1x

F/K Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
TPTX gelir tablosu (TTM)
GelirUS$1.01m
Gelir MaliyetiUS$0
Brüt KârUS$1.01m
Diğer GiderlerUS$343.32m
Kazançlar-US$342.31m

Son Raporlanan Kazançlar

Jun 30, 2022

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)-6.84
Brüt Marj100.00%
Net Kâr Marjı-33,959.03%
Borç/Özkaynak Oranı0%

TPTX uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün